📰 Tom Plitz News
Tom Plitz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tom Plitz. Real-time updates on events, politics, business and more.
April 10, 2022
Relief Reports Full-Year 2021 Results and Provides Corporate Update
March 31, 2022
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant
March 31, 2022
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-202...
December 20, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
December 18, 2020
GENEVA, SWITZERLAND / ACCESSWIRE / December 18, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterdays Extraordinary General Meeting (" EGM") were approved with a large majority (more than 90 percent) of the represented votes. As a result of the exceptional circumstances du...
December 18, 2020
RELIEF THERAPEUTICS Holdings A EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority 18.12.2020 / 07:00 RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (avipt...
December 18, 2020
12/18/2020 | Press release | Distributed by Public on 12/18/2020 00:05 Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (Relief or the Company), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday...